Tuesday June 20, 2023 9:00am – 5:00pm MDT

Building upon pioneering research from over half a century ago exploring the efficacy and safety of psychedelics for treating psycho-spiritual and existential distress in advanced cancer, research is again investigating the therapeutic utility of psychedelics in end-of-life and palliative care. Clinicians and others interested in novel therapies for treating emotional suffering near the end of life and in hospice and palliative care will learn about the history, scientific findings from FDA-approved trials, and implications of the psychedelic treatment model as they consider how psychedelic psychotherapy might serve their patient populations. This presentation will also include discussions on the nature of emotional suffering in advanced illness, the importance of death awareness, and a description of the psychedelic therapeutic model for palliative care.